Physician profile

Justin Mann

Interventional Pain Medicine · Jacksonville, FL

NPI 1790075703

$243,124.48

in general payments reported to CMS, 2019-2025

42 companies · $27K in 2025

The $27K reported for 2025 was more than what 97% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

See the full distribution for Interventional Pain Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$85,525.00
Travel and Lodging$8,965.20
Food and Beverage$7,029.46
Consulting Fee$980.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $203,896.08 2021-2025 Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray
Medtronic USA, INC. $33,513.23 2019-2020
Kowa Pharmaceuticals America, INC. $1,324.83 2022
Abbott Laboratories $1,147.02 2019-2025 Proclaim, Eterna
Amgen INC. $379.58 2020-2022
Radius Health, INC. $322.29 2021-2022
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $302.92 2019-2025 Relistor
Boston Scientific Corporation $284.70 2020-2025 Wavewriter Alpha Prime 16, Superion Indirect Decompression System
Abbvie INC. $243.30 2021-2024
Lundbeck LLC $230.60 2022-2024 Vyepti
Painteq LLC $147.24 2023-2024 Painteq
Interventional Pain Technologies INC. $146.43 2021
Avanos Medical $114.35 2022
Spr Therapeutics, INC $95.51 2023-2025 Sprint Pns System
Stryker Corporation $88.06 2021-2025 Mild Device Kit
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Pacira Therapeutics, INC. $74.75 2019-2021
Scilex Pharmaceuticals INC. $74.07 2020-2023 Ztlido
Arbor Pharmaceuticals, INC. $70.59 2019-2021
Stimwave Technologies Incorporated $63.13 2019-2021
Tersera Therapeutics LLC $61.06 2019
Nevro Corp. $54.97 2019-2022
Redhill Biopharma INC. $53.57 2020-2022
Mml US, INC. $46.79 2025 Reactiv8
Saluda Medical Americas, INC. $33.34 2025 Evoke
Novartis Pharmaceuticals Corporation $29.90 2020-2021
Vertos Medical, INC. $29.20 2020-2021
Pfizer INC. $26.93 2021
Sonex Health, INC. $26.41 2021
Biohaven Pharmaceutical Holding Company LTD. $24.31 2022
Biotronik Nro, INC. $23.25 2025 Prospera
Depuy Synthes Sales INC. $19.86 2023 Orthovisc, Monovisc
Amneal Pharmaceuticals LLC $19.38 2023 Lyvispah
Allergan, INC. $18.00 2019
Curonix LLC $17.53 2023 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Sanofi-Aventis U.S. LLC $16.69 2019
Merz North America, INC. $16.59 2019
Hikma Pharmaceuticals USA $15.94 2022
Almatica Pharma LLC $15.49 2021
Lilly USA, LLC $15.41 2021
Ferring Pharmaceuticals INC. $14.66 2020
Ibsa Pharma INC. $13.94 2024 Tirosint, Licart
Horizon Therapeutics Plc $12.58 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Justin Mann

$243,124.48

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $27K reported for 2025 was more than what 97% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

https://glasscript.com/doctor/1154795/justin-mann

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.